Adjust assumptions
Adjust the usable peer mix to see how each valuation multiple moves the blended fair value.
Peer-implied fair value
—
Blended value per share under the current mix.
Current price
—
Market price unavailable
Peer gap
N/A
Peer gap unavailable
Weighting mixer
No usable valuation methods are available for this peer set.
Value contribution
5 peers →Assign weight to at least one usable method to see the contribution split.
Equal-weight baseline
The simple average of every usable peer method, before your weighting adjustments.
Baseline equity value
—
Baseline / share
—
Relative valuation prices this company against what the market already pays for its peers. For a cash-flow view that does not inherit peer sentiment, open the intrinsic model.
Spreadsheet data
Audit the saved peer set and the method inputs behind the blended fair value.
The saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market cap | Enterprise value | Revenue | EBITDA | Net income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
AMGN AMGEN INC FY ended Feb 10, 2026 | — | — | — | $36.75B | $14.04B | $7.71B | — | — | — |
GILD GILEAD SCIENCES, INC. FY ended Feb 13, 2026 | — | — | — | $29.44B | $13.51B | $8.51B | — | — | — |
BIIB BIOGEN INC. FY ended Feb 04, 2026 | — | — | — | $9.89B | $2.60B | $1.29B | — | — | — |
MRNA Moderna, Inc. FY ended Feb 13, 2026 | — | — | — | $1.94B | -$2.76B | -$2.82B | — | — | — |
ILMN ILLUMINA, INC. FY ended Feb 06, 2026 | — | — | — | $4.34B | $1.43B | $850.00M | — | — | — |
AMGN
AMGEN INC
—
—
—
$36.75B
$14.04B
—
—
—
Cap —EV —Rev $36.75BEBITDA $14.04BP/E —P/S —EV/EBITDA —
GILD
GILEAD SCIENCES, INC.
—
—
—
$29.44B
$13.51B
—
—
—
Cap —EV —Rev $29.44BEBITDA $13.51BP/E —P/S —EV/EBITDA —
BIIB
BIOGEN INC.
—
—
—
$9.89B
$2.60B
—
—
—
Cap —EV —Rev $9.89BEBITDA $2.60BP/E —P/S —EV/EBITDA —
MRNA
Moderna, Inc.
—
—
—
$1.94B
-$2.76B
—
—
—
Cap —EV —Rev $1.94BEBITDA -$2.76BP/E —P/S —EV/EBITDA —
ILMN
ILLUMINA, INC.
—
—
—
$4.34B
$1.43B
—
—
—
Cap —EV —Rev $4.34BEBITDA $1.43BP/E —P/S —EV/EBITDA —
Which peer averages feed the weighted fair value, and which methods are excluded.
| Method | Type | Avg. multiple | Coverage | Implied equity value | Fair value / share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | — | 0/5 | — | — | No saved peers have usable coverage for this method. |
Price / Sales PSExcluded | Equity Multiple | — | 0/5 | — | — | No saved peers have usable coverage for this method. |
Price / Earnings PEExcluded | Equity Multiple | — | 0/5 | — | — | No saved peers have usable coverage for this method. |
EV / EBITDA
EV · Enterprise Multiple
Avg. multiple
—
Coverage
0/5
Implied equity value
—
Fair value / share
—
No saved peers have usable coverage for this method.
Price / Sales
PS · Equity Multiple
Avg. multiple
—
Coverage
0/5
Implied equity value
—
Fair value / share
—
No saved peers have usable coverage for this method.
Price / Earnings
PE · Equity Multiple
Avg. multiple
—
Coverage
0/5
Implied equity value
—
Fair value / share
—
No saved peers have usable coverage for this method.
